A literature review on Janus kinase (JAK) inhibitors for the treatment of immunobullous disorders

Y Kalantari, S Sadeghi, D Asadi, A Goodarzi - International …, 2022 - Elsevier
Janus kinases (JAKs) are a group of intracytoplasmic tyrosine kinase proteins that bind to
the cytoplasmic part of the transmembrane cytokine receptors and regulate signaling. The …

COVID vaccination in patients under treatment with rituximab: a presentation of two cases from Iran and a review of the current knowledge with a specific focus on …

P Hatami, K Balighi, H Nicknam Asl… - Dermatologic …, 2022 - Wiley Online Library
SARS‐COV2 vaccines were approved without long‐term monitoring due to emergent
situations. This has raised some issues about the timing and protocol of receiving vaccines …

A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata

N Ghandi, R Daneshmand, P Hatami, R Abedini… - International …, 2021 - Elsevier
Background Alopecia areata (AA) is a chronic autoimmune disorder. Finding the best
treatment regimen for it remains a challenge. Currently, one of the best documented …

A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns

S Tavakolpour, Z Aryanian, F Seirafianpour… - …, 2021 - Taylor & Francis
Background Rituximab is a FDA-approved monoclonal antibody for adults with moderate to
severe potentially life-threatening pemphigus vulgaris. Recent studies have focused on …

Multiple cycles of rituximab therapy for pemphigus: a group of patients with difficult‐to‐treat disease or a consequence of late rituximab initiation?

K Balighi, P Hatami, MJ Sheikh Aboli… - Dermatologic …, 2022 - Wiley Online Library
Pemphigus is a serious autoimmune disease with few appropriate therapeutic options.
Although rituximab (RTX) has recently shown great promise in this regard, the best protocol …

High Incidence of Metabolic Syndrome Components in Lichen Planus Patients: A Prospective Cross‐Sectional Study

Z Aryanian, A Shirzadian, P Hatami… - International Journal of …, 2022 - Wiley Online Library
Background. Lichen planus (LP) is a chronic inflammatory dermatosis, involving the skin,
appendages, and mucous membranes. There is a growing body of evidence about higher …

[HTML][HTML] Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus …

X Peng, S Wang, K Wu, C Cook, L Li, Z Wang… - Journal of …, 2024 - Elsevier
Pemphigus is a severe autoimmune blistering disease characterized by acantholysis
triggered by autoantibodies against desmoglein 1 and 3 (DSG1/3). Apoptosis plays a pivotal …

A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata

A Al Bazzal, P Hatami, R Abedini, I Etesami… - International …, 2021 - Elsevier
Background Alopecia areata (AA) is a chronic disorder and the best treatment regimen for it
is unknown. Currently, one of the best documented treatment modalities for AA is topical …

Serious health threat of mucormycosis during the ongoing COVID‐19 pandemic: what dermatologists need to know in this regard

P Hatami, K Balighi, H Nicknam Asl… - International Journal of …, 2022 - Wiley Online Library
Background Recently, a surge of mucormycosis in patients affected with or recovered from
SARS‐Cov‐2 has been noted, especially in developing countries such as India, Pakistan …

SARS‐CoV‐2 vaccination and practical points in psoriasis patients: a narrative review

Z Aryanian, K Balighi, P Hatami, A Goodarzi… - Dermatologic …, 2022 - Wiley Online Library
SARS‐CoV2 vaccines were approved without long‐term monitoring due to emergent
situations. This has raised some issues about timing and protocol of receiving vaccines in …